Medical Enterprises Distribution is a privately held developer of surgical impactor technology, which will help DePuy Synthes to provide better solutions for orthopedic surgery.

The company developed automated ME1000 surgical impactor, which has been developed for use in hip replacement.

The ME1000 is a battery-powered device, which automates bone preparation, implant assembly and positioning in total hip arthroplasty (THA).

The device has been developed to replace the handheld mallet used in the procedure, helping to reduce surgeon fatigue and work-related injuries.

Medical Enterprises Distribution’s surgical impactor can be used in various surgical approaches, including the anterior approach.

For anterior approach, DePuy Synthes already provides implants such as Actis total hip system that can accommodate surgeon preference and expertise.

DePuy Synthes already has an exclusive marketing agreement with JointPoint to co-market a hip navigation system, which enables digital templating and precise analysis of implant selection and positioning during THA.

DePuy Synthes is planning to apply surgical impactor technology in a range of orthopaedic surgery procedures.

Subject to antitrust clearance and other customary closing conditions, the deal is expected to complete in the second quarter of this year.

DePuy Synthes Company Group chairman Ciro Rӧmer said: “The role that automation and digital technology are playing in orthopaedics, including joint replacement surgery, is tremendous, and our goal is to be at the forefront of providing surgeons with innovative and differentiated solutions that help increase efficiency as well as generate more predictable and reproducible patient outcomes.

“The acquisition of assets of Medical Enterprises Distribution is a key example of going beyond the implant to provide complete solutions to achieve better outcomes.”

DePuy Synthes provides orthopedic solutions for joint reconstruction, trauma, craniomaxillofacial and spinal surgery.